CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock
16.24 USD
+0.18 (+1.12%)
16.3 USD
+0.06 (+0.37%)
CLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Energy Equipment & Services industry. CLB has an excellent financial health rating, but there are some minor concerns on its profitability. CLB is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CLB had positive earnings in the past year.
In the past year CLB had a positive cash flow from operations.
CLB had positive earnings in 4 of the past 5 years.
CLB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CLB has a better Return On Assets (5.43%) than 68.33% of its industry peers.
Looking at the Return On Equity, with a value of 11.84%, CLB is in the better half of the industry, outperforming 71.67% of the companies in the same industry.
The Return On Invested Capital of CLB (9.29%) is better than 71.67% of its industry peers.
CLB had an Average Return On Invested Capital over the past 3 years of 8.80%. This is in line with the industry average of 7.35%.
The last Return On Invested Capital (9.29%) for CLB is above the 3 year average (8.80%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
CLB has a Profit Margin (6.21%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
CLB has a Operating Margin (11.16%) which is comparable to the rest of the industry.
CLB's Operating Margin has declined in the last couple of years.
CLB has a Gross Margin of 19.95%. This is in the lower half of the industry: CLB underperforms 70.00% of its industry peers.
CLB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CLB has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLB has more shares outstanding
Compared to 1 year ago, CLB has an improved debt to assets ratio.
2.2 Solvency
CLB has an Altman-Z score of 3.28. This indicates that CLB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.28, CLB belongs to the best of the industry, outperforming 81.67% of the companies in the same industry.
The Debt to FCF ratio of CLB is 3.32, which is a good value as it means it would take CLB, 3.32 years of fcf income to pay off all of its debts.
CLB has a better Debt to FCF ratio (3.32) than 65.00% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that CLB is not too dependend on debt financing.
CLB has a Debt to Equity ratio (0.42) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.28 |
ROIC/WACC1.08
WACC8.63%
2.3 Liquidity
CLB has a Current Ratio of 2.37. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
CLB's Current ratio of 2.37 is fine compared to the rest of the industry. CLB outperforms 68.33% of its industry peers.
CLB has a Quick Ratio of 1.76. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
CLB's Quick ratio of 1.76 is fine compared to the rest of the industry. CLB outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
The earnings per share for CLB have decreased by -9.41% in the last year.
CLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.14% yearly.
CLB shows a decrease in Revenue. In the last year, the revenue decreased by -1.02%.
The Revenue has been decreasing by -4.75% on average over the past years.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
Based on estimates for the next years, CLB will show a small growth in Revenue. The Revenue will grow by 3.47% on average per year.
EPS Next Y-15.64%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-1.9%
Revenue Next 2Y1.16%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.09, CLB is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as CLB.
CLB is valuated rather cheaply when we compare the Price/Earnings ratio to 26.38, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 19.47, which indicates a rather expensive current valuation of CLB.
CLB's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CLB to the average of the S&P500 Index (23.83), we can say CLB is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.09 | ||
| Fwd PE | 19.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLB is valued more expensive than 85.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLB is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.99 | ||
| EV/EBITDA | 11.55 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
5. Dividend
5.1 Amount
CLB has a yearly dividend return of 0.25%, which is pretty low.
Compared to an average industry Dividend Yield of 1.28, CLB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 1.87, CLB's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has been paying a dividend for at least 10 years, so it has a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
5.83% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.83%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
16.24
+0.18 (+1.12%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.36%
Inst Owner Change-3.6%
Ins Owners1.02%
Ins Owner Change0.11%
Market Cap756.13M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target15.64 (-3.69%)
Short Float %8.6%
Short Ratio7.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)11.51%
EPS NQ rev (1m)1.8%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)2.08%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)1.96%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.09 | ||
| Fwd PE | 19.47 | ||
| P/S | 1.46 | ||
| P/FCF | 21.99 | ||
| P/OCF | 15.21 | ||
| P/B | 2.79 | ||
| P/tB | 4.58 | ||
| EV/EBITDA | 11.55 |
EPS(TTM)0.77
EY4.74%
EPS(NY)0.83
Fwd EY5.14%
FCF(TTM)0.74
FCFY4.55%
OCF(TTM)1.07
OCFY6.57%
SpS11.11
BVpS5.83
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.28 |
F-Score7
WACC8.63%
ROIC/WACC1.08
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-15.64%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-1.9%
Revenue Next 2Y1.16%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year10.41%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status for CLB stock?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 21.09 and the Price/Book (PB) ratio is 2.79.
Can you provide the financial health for CLB stock?
The financial health rating of CORE LABORATORIES INC (CLB) is 7 / 10.